Name | INVITRO-SIBIR', OOO |
|---|
INN | 5402525254 |
|---|
KPP | 540201001 |
|---|
OGRN | 1105402003904 |
|---|
OKPO | 66205927 |
|---|
Address | 630049, Novosibirskaya Oblast', g. Novosibirsk, pr-kt Krasnyy, d. D.218/2 |
|---|
Phone | 344-97-27 Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 86.90.9 | Core activity | Other independent activities in health care | | 46.46 | Additional activity | Wholesale of pharmaceutical goods | | 47.73 | Additional activity | Retailing drugs in specialized stores (pharmacies) | | All types of activities | | 53.20.3 | Additional activity | Parcel services, not by universal service providers | | 86.21 | Additional activity | General practice | | 86.90.2 | Additional activity | Massage parlors, Krankengymnastikprax., Prax. v. Medicine. Lifeguard (-in), |
Registration date | 07.04.2010 |
|---|
Registering department | Inspektsiya Federal'noy nalogovoy sluzhby po Zael'tsovskomu rayonu g. Novosibirska |
|---|
|
INVITRO-SIBIR', OOO (Novosibirsk Oblast; INN 5402525254) was registered on 7 Apr 2010. The company's authorized capital as of July 1, 2012 was 7610000 rub. Type of ownership of INVITRO-SIBIR', OOO - Limited liability companies. Form of ownership of INVITRO-SIBIR', OOO - Combines private and foreign property. Principal activities of INVITRO-SIBIR', OOO: other independent activities in health care (86.90.9), wholesale of pharmaceutical goods (46.46), retailing drugs in specialized stores (pharmacies) (47.73). |
Economic indicators2023
Net profit (RAS) of INVITRO-SIBIR', OOO grew over 2023 by 5.56% to 704.60 million RUB from 667.45 million RUB over 2022, the company informed. Revenue increased in the accounting period by 9.39% to 4.03 billion RUB from 3.68 billion RUB over 2022; cost of goods sold grew by 7.93% to 2.33 billion RUB from 2.16 billion RUB; sales profit went up by 16.70% to 766.88 million RUB from 657.13 million RUB. 2022
Net profit (RAS) of INVITRO-SIBIR', OOO dropped in 2022 by 31.62% to 667.45 million RUB from 976.09 million RUB over the same period in 2021, the company informed. Revenue decreased in the accounting period by 11.86% to 3.68 billion RUB from 4.18 billion RUB in 2021; cost of goods sold decreased by 6.72% to 2.16 billion RUB from 2.32 billion RUB; sales profit fell by 35.21% to 657.13 million RUB from 1.01 billion RUB. 2021
Net profit (RAS) of INVITRO-SIBIR', OOO grew over 2021 1.74 times to 976.09 million RUB from 561.08 million RUB over 2020, the company informed. Revenue increased in the accounting period by 45.26% to 4.18 billion RUB from 2.88 billion RUB over 2020; cost of goods sold grew by 37.46% to 2.32 billion RUB from 1.69 billion RUB; sales profit went up 1.70 times to 1.01 billion RUB from 595.54 million RUB. 2020
Net profit (RAS) of INVITRO-SIBIR', OOO grew over 2020 2.77 times to 561.08 million RUB from 202.48 million RUB over 2019, the company informed. Revenue increased in the accounting period by 33.59% to 2.88 billion RUB from 2.15 billion RUB over 2019; cost of goods sold grew by 17.48% to 1.69 billion RUB from 1.43 billion RUB; sales profit went up 2.59 times to 595.54 million RUB from 230.27 million RUB. 2019
Net profit (RAS) of INVITRO-SIBIR', OOO grew over 2019 by 45.07% to 202.48 million RUB from 139.57 million RUB over 2018, the company informed. Revenue increased in the accounting period by 22.59% to 2.15 billion RUB from 1.76 billion RUB over 2018; cost of goods sold grew by 4.87% to 1.43 billion RUB from 1.37 billion RUB; sales profit went up by 32.98% to 230.27 million RUB from 173.16 million RUB. 2018
Net profit (RAS) of INVITRO-SIBIR', OOO grew over 2018 by 35.07% to 139.57 million RUB from 103.33 million RUB over 2017, the company informed. Revenue increased in the accounting period by 18.76% to 1.76 billion RUB from 1.48 billion RUB over 2017; cost of goods sold grew by 21.48% to 1.37 billion RUB from 1.13 billion RUB; sales profit went up by 13.53% to 173.16 million RUB from 152.53 million RUB. 2017
Net profit (RAS) of INVITRO-SIBIR', OOO dropped in 2017 by 36.83% to 103.33 million RUB from 163.58 million RUB over the same period in 2016, the company informed. Revenue increased in the accounting period by 17.22% to 1.48 billion RUB from 1.26 billion RUB over 2016; cost of goods sold grew by 22.45% to 1.13 billion RUB from 919.38 million RUB; sales profit fell by 15.53% to 152.53 million RUB from 180.58 million RUB. 2016
Net profit (RAS) of INVITRO-SIBIR', OOO grew over 2016 by 5.42% to 163.58 million RUB from 155.17 million RUB over 2015, the company informed. Revenue increased in the accounting period by 22.16% to 1.26 billion RUB from 1.03 billion RUB over 2015; cost of goods sold grew by 30.57% to 919.38 million RUB from 704.11 million RUB; sales profit went up by 3.16% to 180.58 million RUB from 175.05 million RUB. 2014
Net profit (RAS) of INVITRO-SIBIR', OOO grew over 2014 by 34.43% to 57.45 million RUB from 42.74 million RUB over 2013, the company informed. Revenue increased in the accounting period by 38.17% to 777.19 million RUB from 562.50 million RUB over 2013; cost of goods sold grew by 38.21% to 465.70 million RUB from 336.94 million RUB; sales profit went up by 37.72% to 87.23 million RUB from 63.34 million RUB. 2013
Net profit (RAS) of INVITRO-SIBIR, OOO grew over 2013 4.87 times to 42.74 million RUB from 8.78 million RUB over 2012, the company informed. Revenue increased in the accounting period by 47.24% to 562.50 million RUB from 382.03 million RUB over 2012; cost of goods sold grew by 41.61% to 336.94 million RUB from 237.94 million RUB; sales profit went up 2.77 times to 63.34 million RUB from 22.83 million RUB. 2012
Net profit (RAS) of INVITRO-Sibir, OOO made up 8.78 million RUB over 2012 compared to net loss of 15.12 million RUB over 2011, the company informed. Cost of goods sold grew 7.49 times to 237.94 million RUB from 31.79 million RUB; sales profit made up 22.83 million RUB compared to sales loss of 18.79 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|